Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia
- Equal contributors
1 Cancer Genetics & Developmental Biology, British Columbia Cancer Research Centre, Vancouver, BC, Canada
2 Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada
3 Obstetrics and Gynaecology, The University of British Columbia, Vancouver, BC, Canada
4 Gynecologic Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada
5 Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada
6 Bioengineering, Rice University, Houston, Texas, USA
7 Gynecologic Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA
8 Cancer Imaging, British Columbia Cancer Research Centre, Vancouver, BC, Canada
BMC Genomics 2008, 9:64 doi:10.1186/1471-2164-9-64Published: 4 February 2008
The highest rates of cervical cancer are found in developing countries. Frontline monitoring has reduced these rates in developed countries and present day screening programs primarily identify precancerous lesions termed cervical intraepithelial neoplasias (CIN). CIN lesions described as mild dysplasia (CIN I) are likely to spontaneously regress while CIN III lesions (severe dysplasia) are likely to progress if untreated. Thoughtful consideration of gene expression changes paralleling the progressive pre invasive neoplastic development will yield insight into the key casual events involved in cervical cancer development.
In this study, we have identified gene expression changes across 16 cervical cases (CIN I, CIN II, CIN III and normal cervical epithelium) using the unbiased long serial analysis of gene expression (L-SAGE) method. The 16 L-SAGE libraries were sequenced to the level of 2,481,387 tags, creating the largest SAGE data collection for cervical tissue worldwide. We have identified 222 genes differentially expressed between normal cervical tissue and CIN III. Many of these genes influence biological functions characteristic of cancer, such as cell death, cell growth/proliferation and cellular movement. Evaluation of these genes through network interactions identified multiple candidates that influence regulation of cellular transcription through chromatin remodelling (SMARCC1, NCOR1, MRFAP1 and MORF4L2). Further, these expression events are focused at the critical junction in disease development of moderate dysplasia (CIN II) indicating a role for chromatin remodelling as part of cervical cancer development.
We have created a valuable publically available resource for the study of gene expression in precancerous cervical lesions. Our results indicate deregulation of the chromatin remodelling complex components and its influencing factors occur in the development of CIN lesions. The increase in SWI/SNF stabilizing molecule SMARCC1 and other novel genes has not been previously illustrated as events in the early stages of dysplasia development and thus not only provides novel candidate markers for screening but a biological function for targeting treatment.